Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears

American Journal of Clinical Pathology

Volumn 105, Issue 3, 1996, Pages 321-326

  Apple, Sophia K ^a   Hecht, J Randolph ^a,c   Novak, Jessica M ^a   Nieberg, Roberta K ^a   Rosenthal, Dorothy L ^b   Grody, Wayne W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytology smears; K ras mutation; Pancreatic adenocarcinoma

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0029960819     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.3.321     Document Type: Article

References (48)

1. Wingo PA, Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995;45:8-30.
2. Saez A, Catala I, Brossa R, Funes A, Jaurrieta E, Ferrer JE. Intraoperative fine-needle aspiration cytology of pancreatic lesions. Acta Cytologica 1995;39:485-488.
3. Rodriguez J, Kasberg C, Nipper M. Schoolar J, Riggs MW, Dyck WP. CT-guided needle biopsy of the pancreas: A retrospective analysis of diagnostic accuracy. J Gastroenterol 1992;87:1610-1613.
4. Moulton JS, Moore PT. Coaxial percutaneous biopsy technique with automated biopsy devices: Value in improving accuracy and negative predictive value. Radiology 1993;186:515-522.
5. Edoute Y, Lemberg S, Malberger E. Preoperative and intraoperative fine-needle aspiration cytology of pancreatic lesions. Am J Gastroenterol 1991;16:1015-1019.
6. Hyoty MK, Mattila JJ, Salo K. Intraoperative fine-needle aspiration cytology examination of pancreatic lesions. Surg Gynecol Obstet 1991;173:193-197.
7. Schadt ME, Kline TS, Neal HS, Scoma RS, Naryshkin S. Intraoperative pancreatic fine needle aspiration biopsy: Results in 166 patients. Am Surg 1991;57:73-75.
8. van Es JM, Polak MM. van den Berg FM, et al. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: Mutation of K-ras and overexpression of the P53 protein product. J Clin Pathol 1995;48:218-222.
9. deMelo MB, Sales TSI, Lorand-Metze I, Costa FF. Rapid method for isolation of DNA from glass slide smears for PCR. Acta Haematol 1992;87:214-215.
10. Sepp R, Szabo I, Uda H, Sakamoto H. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 1994;47:318-323.
11. Wilborn F, Schmidt CA, Siegert W. Demonstration of chimerism after allogeneic bone marrow transplantation by polymerase chain reaction of Y- chromosome-specific nucleotide sequences-chacterization of a new technical approach. Leukemia 1993;7:140-143.
12. Hanson CH, Holbrook EA, Sheldon S, Schnitzer B, Roth MS. Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction. Am J Pathol 1990;137:1-6.
13. Yap EPH, McGee JO'D. Slide PCR: DNA amplification from cell samples on microscopic glass slides. Nucleic Acids Res 1991;19: 4294.
14. Singh J, Kulkarni N, Kelloff G, Reddy BS. Modulation of azoxymethethane mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis 1994;15:1317-1323.
15. Singh J, Kelloff G, Reddy BS. Intermediate biomarkers of colon cancer: Modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis. Carcinogenesis 1993;14:699-704.
16. Watanabe H, Sawabu N, Ohta H, et al. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 1993;84:961-965.
17. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-297.
18. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M. Genetic alterations during colorectal development. N Engl J Med 1988;319:525-532.
19. Neuman WL. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromos Cancer 1991;3:468-473.
20. Rodenhuis S, Slebos RJC, Boot AJM, Evers SG, Mooi MJ, Wagenaar SCC. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 1988;48:5738-5741.
21. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk W, Bos JL. Mutational activation of the K-ras oncogenes: A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987;317:929-935.
22. Shen C, Chang JG, Lee LS, et al. Analysis of Ras gene mutations in gastrointestinal cancers. J Formosan Med Assoc 1991;90:1149-1154.
23. Caduff RF, Johnston CM, Frank TS. Mutations of the K-ras oncogene in carcinoma of the endometrium. Am J Pathol 1995;146: 182-188.
24. Sciacchitano S, Paliotta DS, Nardi F, Sacchi A, Andreoli M, Pontecorvi A. PCR amplification and analysis of ras oncogenes from thyroid cytologic smears. Diagnostic Molecular Pathol 1994;3: 114-121.
25. Wright PA, Lemoirre NR, Mayall ES, Hughes D, Williams ED. Papillary and follicular thyroid carcinomas show a different pattern of ras oncongene mutation. Br J Cancer 1989;60:576-577.
26. Moley JF, Brother MB, Wells SA, Spengler BA, Beidler JL. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas and medullary thyroid cancers. Cancer Res 1991;51:1569-1559.
27. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marchall CJ. Analysis of ras gene mutations in acute myeloid leukemia by PCR and oligonucleotide probes. Proc Natl Acad Sci USA 1988;85:1629-1633.
28. Caldas C, Hahn SH, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic duct hyperplasia. Cancer Res 1994;54:3568-3573.
29. Tsutsumi M, Murakami Y, Kondoh S, et al. Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-Nitrosobis (2-hydroxypropyl)amine. Jpn J Cancer Res 1993;84:956-960.
30. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993;217:138-143.
31. Tabata T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y. The role of ras mutation in pancreatic cancer, precancerous lesions and chronic pancreatitis. Int J Pancreatol 1993;14:237-244.
32. Hruban RH, van Mansfeld ADM, Offerhaus GJA, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. Am J Pathol 1993;143:545-554.
33. Motojima K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanematsu T. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 1991;12:1784-1788.
34. Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirstenras oncogene. Ann Surg 1991;214:657-662.
35. Tada M, Omata M, Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991;100:233-238.
36. Stork P, Loda M, Bosari S, Wiley B, Poppenhusen K, Wolfe H. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerasechain reaction. Oncogene 1991;6:857-862.
37. Tada M, Yokosuka O, Omata M, Ohto M, Isono K. Analysis of Ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990;66: 930-935.
38. Nagata Y, Abe M, Motoshima K, Nakayama E, Shiku H. Frequent Glycine- to-Aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res 1990;81:135-140.
39. Shibata D, Almoguera C, Forrester K, et al. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 1990;50:1279-1283.
40. Grunewald K, Lyons J, Frohlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinoma. Int J Cancer 1989;43:1037-1041.
41. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S. Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 1989;80:622-626.
42. Smit VT, Boot AJ, Smits AA, et al. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988;16:7773-7782.
43. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-554.
44. Tada M, Ometa M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-2474.
45. Berthelemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995;123:188-191.
46. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, Kato Y. Frequent c-Ki-ras oncogene activation in mucinous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-956.
47. Lemoine NR, Jain S, Hughes CM, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992;102: 230-236.
48. DiGiuseppe JA, Hruban HA, Offerhaus GJA, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994;144:889-895.